NLRP3 has been associated with the development of cancer, atherosclerosis (Varghese et al., 2016), currently viewed as predictor for chronic myeloid leukemia (Zhang et al., 2018) and novel diagnostic biomarker for early detection for diabetic nephropathy (El-Horany et al., 2017). This evidence concerns the gene NLRP3 and cancer.